A Phase 2B, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Effects Of EDP-938 In Adult Hematopoietic Cell Transplant Recipients With Acute Respiratory Syncytial Virus Infection Of The Upper Respiratory Tract
Principal Investigator(s)
Email for information
Funded by
HJF
Research Start Date
Status
Inactive
The primary objective of the study is to evaluate the effect of EDP-938 on the development of lower respiratory tract complication (LRTC) in HCT subjects with an acute RSV infection of the upper respiratory tract.
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.